| Financial Year |
March 31 2023 |
| Monetary Funds |
19,408,885,098.00 |
| Held-for-trading Financial Assets |
6,580,267.00 |
| Notes Receivable |
464,509,126.00 |
| Accounts Receivable |
4,853,228,993.00 |
| Advances to Suppliers |
258,935,855.00 |
| Other Receivables |
137,204,044.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
5,428,227,317.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
111,498,954.00 |
| Total Current Assets |
32,009,756,589.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
316,416,243.00 |
| Long-term Equity Investment |
250,282,500.00 |
| Investment Properties |
-- |
| Fixed Assetes |
14,317,971,270.00 |
| Under-construction Projects |
3,733,531,660.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,325,334,328.00 |
| R&D expenses |
-- |
| Goodwill |
154,940,513.00 |
| Long-Term Deferred and Prepaid Expenses |
505,629,677.00 |
| Deferred Income Tax Assets |
401,883,294.00 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
21,692,497,120.00 |
| Total Assets |
53,702,253,709.00 |
| Short-Term Loans |
7,636,397,305.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,361,784,098.00 |
| Accounts Payable |
1,747,922,071.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
395,821,088.00 |
| Taxes Payable |
399,339,514.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,503,461,850.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,050,902,335.00 |
| Other Current Liabilities |
302,090,064.00 |
| Sub-Total of Current Liabilities |
16,365,251,486.00 |
| Long-term Loans |
6,102,200,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
65,218,479.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
219,472,566.00 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
7,544,578,359.00 |
| Total Liabilities |
23,909,829,845.00 |
| Paid-In Capital(Or Share Stock) |
2,609,743,532.00 |
| Capital Surplus |
9,700,750,924.00 |
| Surplus Reserve |
3,581,885,299.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
13,904,302,637.00 |
| Minority Stockholder's Interest |
-14,778,301.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
29,807,202,165.00 |
| Owner's Equity（Stockholder's Equity） |
29,792,423,864.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
53,702,253,709.00 |
